Vaxcyte Statistics
Total Valuation
Vaxcyte has a market cap or net worth of $9.17 billion. The enterprise value is $7.49 billion.
Important Dates
The last earnings date was Tuesday, February 25, 2025, after market close.
Earnings Date | Feb 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Vaxcyte has 128.76 million shares outstanding. The number of shares has increased by 25.57% in one year.
Current Share Class | 128.76M |
Shares Outstanding | 128.76M |
Shares Change (YoY) | +25.57% |
Shares Change (QoQ) | +9.30% |
Owned by Insiders (%) | 0.70% |
Owned by Institutions (%) | 103.96% |
Float | 119.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.69 |
P/TBV Ratio | 2.77 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.75, with a Debt / Equity ratio of 0.02.
Current Ratio | 12.75 |
Quick Ratio | 12.61 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.41% and return on invested capital (ROIC) is -15.32%.
Return on Equity (ROE) | -20.41% |
Return on Assets (ROA) | -14.47% |
Return on Invested Capital (ROIC) | -15.32% |
Return on Capital Employed (ROCE) | -16.89% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.12M |
Employee Count | 414 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.03% in the last 52 weeks. The beta is 1.02, so Vaxcyte's price volatility has been similar to the market average.
Beta (5Y) | 1.02 |
52-Week Price Change | -0.03% |
50-Day Moving Average | 83.48 |
200-Day Moving Average | 89.13 |
Relative Strength Index (RSI) | 33.42 |
Average Volume (20 Days) | 1,186,423 |
Short Selling Information
The latest short interest is 13.33 million, so 10.36% of the outstanding shares have been sold short.
Short Interest | 13.33M |
Short Previous Month | 13.53M |
Short % of Shares Out | 10.36% |
Short % of Float | 11.19% |
Short Ratio (days to cover) | 11.45 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -569.55M |
Pretax Income | -497.19M |
Net Income | -463.93M |
EBITDA | -562.54M |
EBIT | -569.55M |
Earnings Per Share (EPS) | -$3.80 |
Full Income Statement Balance Sheet
The company has $1.75 billion in cash and $71.11 million in debt, giving a net cash position of $1.68 billion or $13.02 per share.
Cash & Cash Equivalents | 1.75B |
Total Debt | 71.11M |
Net Cash | 1.68B |
Net Cash Per Share | $13.02 |
Equity (Book Value) | 3.31B |
Book Value Per Share | 26.47 |
Working Capital | 1.65B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$452.63 million and capital expenditures -$119.16 million, giving a free cash flow of -$571.79 million.
Operating Cash Flow | -452.63M |
Capital Expenditures | -119.16M |
Free Cash Flow | -571.79M |
FCF Per Share | -$4.44 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |